Mars Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.99 M
- Revenue Growth -3.24%
- Profit Growth -71.69%
- Ebitda 281.30%
- Net Worth 11.80%
- Total Assets 6.93%
About Mars Diagnostics
Mars Diagnostics Private Limited (MDPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 April 2016 (Eight years and nine months 27 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.99 M.
Piyush Gupta and Sweta Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300DL2016PTC298777
- Company No.
298777
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Mars Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Gupta  | Director | 30-Apr-2016 | Current |
| Sweta Gupta | Director | 30-Apr-2016 | Current |
Financial Performance of Mars Diagnostics.
Mars Diagnostics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.24% decrease. The company also saw a substantial fall in profitability, with a 71.69% decrease in profit. The company's net worth Soared by an impressive increase of 11.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mars Diagnostics?
Unlock access to Mars Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹9.99 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2022 | Others | ₹4.00 M | Open |
| 31 Jul 2018 | Others | ₹5.99 M | Open |
How Many Employees Work at Mars Diagnostics?
Unlock and access historical data on people associated with Mars Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mars Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mars Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.